{
    "nctId": "NCT04274946",
    "briefTitle": "Sentinel Lymph Node Biopsy With Hybrid Technique in Breast Cancer",
    "officialTitle": "The Comparative Analysis of Multimodal Markers to Identify Sentinel Lymph Node in Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Identification rate of sentinel lymph node",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed primary breast cancer by core needle, incisional or excisional biopsy\n* cN0 patients\n* In patients with abnormal axillary lymph nodes sonographically US-guided FNA cytology of these nodes were performed and FNA cytology negative patients planed to undergo SLNB with different mapping techniques.\n\nExclusion Criteria:\n\n* Patients with neoadjuvant therapy\n* Patients with pathological diagnosed ductal carcinoma in situ by excisional biopsy\n* Patients with pathologically proven axillary disease\n* Patients with T4d tumor",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}